Glipizide Tablet, Film Coated, Extended Release
Product Images NDC 70518-1848

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 70518-1848). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glipizide 10mg 70518 1848 00

Glipizide 10 mg extended-release tablet packaging label showing a quantity of 90 tablets. The label includes the product name, strength, dosage form, and indicates it is for prescription use only. It also displays the labeler RemedyRepack Inc., and manufacturer Rising Pharma, Inc., along with storage instructions and a QR code.*

FDA Label Image

Glipizide 10mg 70518 1848 01

Glipizide 10 mg extended-release film coated tablets, 30 count, repackaged by RemedyRepack Inc. The label includes NDC 70518-1848-01 and states storage instructions and manufacturer information for Rising Pharma, Inc., Allendale, NJ.*

FDA Label Image

Structural Formula (Structural Formula)

Chemical structure diagram showing the molecular composition of Glipizide, the active ingredient. The structure includes aromatic rings, sulfonyl, amide, and cyclohexyl functional groups, consistent with Glipizide's known chemical makeup.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.